Related Experiment Video
Updated: Aug 24, 2026

08:44
Preparation, Administration, and Assessment of In Vivo Tissue-Specific Cellular Uptake of Fluorescent Dye-Labeled Liposomes
Published on: July 30, 2020
Development of a liposome formulation of ethambutol
Theresa Wiens1, Thomas Redelmeier, Yossef Av-Gay
1Division of Infectious Diseases, Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada V5Z 3J5.
Antimicrobial Agents and Chemotherapy
|April 24, 2004
Abstract:
A liposomal formulation capable of encapsulating 76 to 92% of the antimycobacterial drug ethambutol and showing prolonged in vitro release kinetics is described. In vitro efficacy is equivalent to that of the free drug, suggesting that encapsulation of ethambutol has the potential to shorten the current regimens for tuberculosis.

